FR-171113

This small molecule antagonist selectively inhibits protease-activated receptor 1 (PAR1), a key thrombin receptor. It is a valuable research tool for studying thrombosis, inflammation, and cancer in both cellular assays and animal models, as evidenced by its use in published in vitro and in vivo studies.